Ginkgo Bioworks Holdings (DNA) Return on Capital Employed (2021 - 2026)

Ginkgo Bioworks Holdings has reported Return on Capital Employed for 6 years, with the latest figure at 29.86% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 807.0% year-over-year to 29.86%; the trailing twelve-month figure through Mar 2026 stood at 29.86% (up 807.0% YoY), and the FY2025 full-year result was 27.35%, up 1223.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 29.86%, down from 29.03% in the prior quarter.
• The five-year high for Return on Capital Employed was 26.2% in Q2 2025, with the low at 202.63% in Q3 2022.
• Historically, Return on Capital Employed has averaged 70.03% across 5 years, with a median of 51.39% in 2023.
• Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 19183 bps — and 2023, when it surged 15656 bps.
• Ginkgo Bioworks Holdings' Return on Capital Employed stood at 108.71% in 2022, then surged by 53 bps to 51.39% in 2023, then rose by 18 bps to 42.34% in 2024, then soared by 31 bps to 29.03% in 2025, then decreased by 3 bps to 29.86% in 2026.
• The last three Return on Capital Employed figures came in at 29.86% (Q1 2026), 29.03% (Q4 2025), and 31.07% (Q3 2025), per Business Quant data.